Association between patient education and health-related quality of life in patients with Parkinson's disease

Quality of Life Research

Volumn 13, Issue 1, 2004, Pages 81-89

  Shimbo, T ^a   Goto, M ^a   Morimoto, T ^a   Hira, K ^a   Takemura, M ^b   Matsui, K ^a   Yoshida, A ^a   Fukui, T ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Yasaka Town Hospital   (Japan)

Author keywords

Informational support; Parkinson's disease; Patient education; Quality of life; SF 36

Indexed keywords

AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; EMOTIONAL STRESS; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NEUROLOGICAL COMPLICATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PATIENT SATISFACTION; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; RANDOMIZATION; SCORING SYSTEM; SOCIAL ASPECT;

AGED; CROSS-SECTIONAL STUDIES; DISEASE MANAGEMENT; FEMALE; HUMANS; JAPAN; LINEAR MODELS; MALE; NATIONAL HEALTH PROGRAMS; PARKINSON DISEASE; PATIENT EDUCATION; PATIENT SATISFACTION; PROGRAM EVALUATION; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 1542285318     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:QURE.0000015306.59840.95     Document Type: Article

References (41)

1. Interpretation of medical insurance tariff (Japanese). Tokyo: Institute of Social Insurance, 2000.
2. The Global Parkinson's Disease Survey (GPDS) Steering Committee. Factors impacting on quality of life in Parkinson's disease: Results from an international survey. Mov Disord 2002; 17: 60-67.
3. Montgomery EB Jr, Lieberman A, Singh G, Fries JF. Patient education and health promotion can be effective in Parkinson's disease: A randomized controlled trial. PROPATH Advisory Board. Am J Med 1994; 97: 429-435.
4. Mercer BS. A randomized study of the efficacy of the PROPATH Program for patients with Parkinson disease. Arch Neurol 1996; 53: 881-884.
5. Rodgers H, Atkinson C, Bond S, Suddes M, Dobson R, Curless R. Randomized controlled trial of a comprehensive stroke education program for patients and caregivers. Stroke 1999; 30: 2585-2591.
6. Mannix LK, Solomon, GD, Kippes CM, Kunkel RS. Impact of headache education program in the workplace. Neurology 1999; 53: 868-871.
7. Clark NM, Janz NK, Becker MH, et al. Impact of self-management education on the functional health status of older adults with heart disease. Gerontologist 1992; 32: 438-443.
8. Schaefer C, Coyne JC, Lazarus RS. The health-related functions of social support. J Behav Med 1981; 4: 381-406.
9. Swindells S, Mohr J, Justis JC, et al. Quality of life in patients with human immunodeficiency virus infection: Impact of social support, coping style and hopelessness. Int J STD AIDS 1999; 10: 383-391.
10. Bastardo YM, Kimberlin CL. Relationship between quality of life, social support and disease-related factors in HIV-infected persons in Venezuela. AIDS Care 2000; 12: 673-684.
11. King RB. Quality of life after stroke. Stroke 1996; 27: 1467-1472.
12. Woloshin S, Schwartz LM, Tosteson AN, et al. Perceived adequacy of tangible social support and health outcomes in patients with coronary artery disease. J Gen Intern Med 1997; 12: 613-618.
13. Bosworth HB, Siegler IC, Olsen MK, et al. Social support and quality of life in patients with coronary artery disease. Qual Life Res 2000; 9: 829-839.
14. Hashimoto H, Iwao Y, Hibi T, et al. A model for quality of life in the patients with Crohn's disease (Japanese). Nihon Shokakibyo-Gakkaizasshi (Jpn J Gastroenterol) 1999; 96: 1258-1265.
15. Bae SC, Hashimoto H, Karlson EW, Liang MH, Daltroy LH. Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol 2001; 28: 1245-1251.
16. Cohen S, Mermelstein R, Kamarck T, Hoberman HM. Measuring the functional components of social support. In: Sarason IR, Sarason BR (eds), Social Support: Theory, Research and Application. The Hague: Martines Nijhoff, 1985, pp. 73-94.
17. Guldvog B. Can patient satisfaction improve health among patients with angina pectoris? Int J Qual Health Care 1999; 11: 233-240.
18. Shimbo T, Hira K, Takemura M, Fukui T. Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan. Pharmacoeconomics 2001; 19: 875-886.
19. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey: I - Conceptual framework and item selection. Med Care 1992; 30: 473-489.
20. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression, and mortality. Neurology 1967; 17: 427-442.
21. Fahn S, Elton R, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds), Recent Developments in Parkinson's Disease, vol. 2. Florham Park, NJ: Macmillan Health Care Information, 1987; 153-163, 293-304.
22. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70: 734-738.
23. McRae C, Diem G, Vo A, O'Brien C, Seeberger L. Reliability of measurements of patient health status: A comparison of physician, patient, and caregiver ratings. Parkinsonism Relat Disord 2002; 8: 187-192.
24. Louis ED, Lynch T, Marder K, Fahn S. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale. Mov Disord 1996; 11: 185-192.
25. Gandhi TK, Burstin HR, Cook EF, et al. Drug complications in outpatients. J Gen Intern Med 2000; 15: 149-154.
26. Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N. Self-reported functioning and well-being in patients with Parkinson's disease: Comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age Ageing 1995; 24: 505-509.
27. Rubenstein LM, Voelker MD, Chrischilles EA, Glenn DC, Wallace RB, Rodnitzky RL. The usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson's disease research. Qual Life Res 1998; 7: 279-290.
28. Damiano AM, McGrath MM, Willian MK, et al. Evaluation of a measurement strategy for Parkinson's disease: Assessing patient health-related quality of life. Qual Life Res 2000; 9: 87-100.
29. Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK. The quality of life in Parkinson's disease. Mov Disord 2000; 15: 216-223.
30. Fukuhara S, Bito S, Grenn J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998; 51: 1037-1044.
31. Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 1998; 51: 1045-1053.
32. SAS Ver 6.12, Cary: SAS Institute, 2000.
33. StatView Ver 5.0, Cary: SAS Institute, 1998.
34. Kusumi M, Nakashima K, Harada H, Nakayama H, Takahashi K. Epidemiology of Parkinson's disease in Yonago City, Japan: Comparison with a study carried out 12 years ago. Neuroepidemiology 1996; 15: 201-207.
35. Kyes KB, Franklin G, Weaver MR. Reliability and validity of medical outcome and patient satisfaction measures among injured workers in Washington State: A pretest. Am J Ind Med 1997; 31: 427-434.
36. Edwards P, Roberts I, Clarke M, et al. Increasing response rates to postal questionnaires: Systematic review. Br Med J 2002; 324: 1183-1191.
37. Gotham AM, Brown RG, Marsden CD. Depression in Parkinson's disease: A quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986; 49: 381-389.
38. Andersen S. Patient perspective and self-help. Neurology 1997; 52(7, Suppl 3): S26-S28.
39. Frazier LD. Coping with disease-related stressors in Parkinson's disease. Gerontologist 2000; 40: 53-63.
40. Cole SA, Bird J. Medical Interview: The Three-Function Approach. 2nd ed. St Louis: Mosby, 2000.
41. Goroll AH, Mulley AG (eds), Primary Care Medicine: Office Evaluation and Management of the Adult Patient. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2000.